bpc 157 peptide human clinical trial BPC-157 5mg bpc-157 human clinical trials evidence
Description
How many doses does a 10mg vial provide This depends entirely on your dosing protocol and which phase of escalation you are in
Higher doses and shorter durations fit acute healing
IFITM1 is implicated in host-pathogen interaction, and IFN- and IFN- can induce expression of IFITM1 in response to pathogens (148)
Peripheral neuropathy symptoms depend on which nerves are affected
